The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 01, 2022

Filed:

Jun. 06, 2017
Applicant:

Polytherics Limited, Cambridge, GB;

Inventors:

Timothy David Jones, Cambridge, GB;

Robert George Edward Holgate, Hertfordshire, GB;

Francis Joseph Carr, Aberdeen, GB;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/68 (2017.01); C07K 16/30 (2006.01); A61K 31/537 (2006.01); A61K 38/08 (2019.01); A61K 49/00 (2006.01); A61K 51/10 (2006.01); C07K 16/46 (2006.01); G01N 33/574 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3069 (2013.01); A61K 31/537 (2013.01); A61K 38/08 (2013.01); A61K 47/6803 (2017.08); A61K 47/6869 (2017.08); A61K 47/6889 (2017.08); A61K 49/0002 (2013.01); A61K 51/1072 (2013.01); C07K 16/468 (2013.01); G01N 33/57434 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/73 (2013.01);
Abstract

An antibody or antigen-binding portion thereof which binds to PSMA and comprises a heavy chain variable domain comprising the sequence given in SEQ ID NO:33, wherein SEQ ID NO:33 is: EVQLVQSGXE XKKPGASVKV SCKXSGYTFT EYTIHWVXQA XGKGLEWIGN INPNXGGTTY NOKFEDRXTXTVDKSTSTAY MELSSLRSED TAVYYCAAGW NFDYWGOGTT VTVSS wherein: Xis A or P Xis V or L Xis A or T Xis R or K Xis P or H Xis N or Q Xis V or A; and Xis I or L whereby the heavy chain variable domain comprises up to 3 amino acid sequence modification(s) between positions 1-30, 36-49, 67-98 and 105-115 of SEQ ID NO: 33. The invention also provides compounds that include the antibody or antigen-binding portion thereof, such as conjugates, and their use in the treatment or diagnosis of diseases, in particular cancers, particularly prostate cancer.


Find Patent Forward Citations

Loading…